Department of Health System Financing, Expenditure and Resource Allocation,WHO and Department of Mental Health and Substance Abuse, WHO
School of Public Health, Queensland University of Technology, Australia
Department of Psychiatry, Hospital Universitario de la Princesa,Universidad Autonoma de Madrid, Spain
Department of Mental Health and Substance Abuse,WHO,Geneva
Correspondence: Dan Chisholm,CEP Team (Room 3169), Department of Health System Financing, Expenditure and Resource Allocation, Evidence and Information for Policy,World Health Organization, 1211 Geneva, Switzerland; e-mail: ChisholmD{at}who.int
See pp.
386392 and
editorial, pp.
379380, this
issue.
Background International evidence on the cost and effects of interventions for reducing the global burden of depression remain scarce.
Aims To estimate the population-level cost-effectiveness of evidence-based depression interventions and their contribution towards reducing current burden.
Method Primary-care-based depression interventions were modelled at the level of whole populations in 14 epidemiological subregions of the world. Total population-level costs (in international dollars or I$) and effectiveness (disability adjusted life years (DALYs) averted) were combined to form average and incremental cost-effectiveness ratios.
Results Evaluated interventions have the potential to reduce the current burden of depression by 1030%. Pharmacotherapy with older antidepressant drugs, with or without proactive collaborative care, are currently more cost-effective strategies than those using newer antidepressants, particularly in lower-income subregions.
Conclusions Even in resource-poor regions, each DALYaverted by efficient depression treatments in primary care costs less than 1 year of average per capita income, making such interventions a cost-effective use of health resources. However, current levels of burden can only be reduced significantlyif there is a substantialincrease substantial increase intreatment coverage.
Related articles in BJP:
This article has been cited by other articles:
![]() |
P. J. van't Veer-Tazelaar, H. W. J. van Marwijk, P. van Oppen, H. P. J. van Hout, H. E. van der Horst, P. Cuijpers, F. Smit, and A. T. F. Beekman Stepped-Care Prevention of Anxiety and Depression in Late Life: A Randomized Controlled Trial Arch Gen Psychiatry, March 1, 2009; 66(3): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Stein, S. Seedat, A. Herman, H. Moomal, S. G. Heeringa, R. C. Kessler, and D. R. Williams Lifetime prevalence of psychiatric disorders in South Africa The British Journal of Psychiatry, February 1, 2008; 192(2): 112 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chisholm, C. Lund, and S. Saxena Cost of scaling up mental healthcare in low- and middle-income countries The British Journal of Psychiatry, December 1, 2007; 191(6): 528 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. TYRER The British Journal of Psychiatry, December 1, 2006; 189(6): 576 - 576. [Full Text] [PDF] |
||||
![]() |
P. TYRER The British Journal of Psychiatry, November 1, 2006; 189(5): 478 - 478. [Full Text] [PDF] |
||||
![]() |
R. Araya, T. Flynn, G. Rojas, R. Fritsch, and G. Simon Cost-Effectiveness of a Primary Care Treatment Program for Depression in Low-Income Women in Santiago, Chile Am J Psychiatry, August 1, 2006; 163(8): 1379 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dixon, D. McDaid, M. Knapp, and C. Curran Financing mental health services in low- and middle-income countries Health Policy Plan., May 1, 2006; 21(3): 171 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. TYRER The British Journal of Psychiatry, May 1, 2006; 188(5): 500 - 500. [Full Text] [PDF] |
||||
![]() |
M. J. Hindin and S. Gultiano Associations Between Witnessing Parental Domestic Violence and Experiencing Depressive Symptoms in Filipino Adolescents Am J Public Health, April 1, 2006; 96(4): 660 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chisholm, M. van Ommeren, J.-L. Ayuso-Mateos, and S. Saxena Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder The British Journal of Psychiatry, December 1, 2005; 187(6): 559 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Hasin, R. D. Goodwin, F. S. Stinson, and B. F. Grant Epidemiology of Major Depressive Disorder: Results From the National Epidemiologic Survey on Alcoholism and Related Conditions Arch Gen Psychiatry, October 1, 2005; 62(10): 1097 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sachdev, F. Fregni, P. Boggio, M. A. Nitsche, and A. Pascual-Leone Transcranial direct current stimulation in developing countries * Authors' reply The British Journal of Psychiatry, August 1, 2005; 187(2): 191 - 192. [Full Text] [PDF] |
||||
![]() |
C. Meyer Depressive disorders were the fourth leading cause of global disease burden in the year 2000 Evid. Based Ment. Health, November 1, 2004; 7(4): 123 - 123. [Full Text] [PDF] |
||||
![]() |
M. J. Crawford Depression: international intervention for a global problem The British Journal of Psychiatry, May 1, 2004; 184(5): 379 - 380. [Full Text] [PDF] |
||||
![]() |
T. B. Ustun, J. L. Ayuso-Mateos, S. Chatterji, C. Mathers, and C. J. L. Murray Global burden of depressive disorders in the year 2000 The British Journal of Psychiatry, May 1, 2004; 184(5): 386 - 392. [Abstract] [Full Text] [PDF] |
||||